Axsome Therapeutics
Axsome Therapeutics is hiring a field-based Regional Marketer to serve as an extension of the Sleep Marketing team, focusing on engagements with key opinion leaders and supporting brand strategy across a large Western territory. The role acts as a bridge between regional markets and headquarters, informs strategic direction through customer insights, and supports speaker development, promotional programs, and congress activities. The position reports to the Senior Director, Regional Marketing for Neurology and requires residency within the assigned geography.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2012
Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Its pipeline and commercial programs include candidates such as AXS-05, AXS-12 and AXS-14, addressing disorders including major depressive disorder, Alzheimer’s disease agitation, migraine, narcolepsy and fibromyalgia. Axsome emphasizes innovative mechanisms of action and rigorous clinical development to deliver meaningful improvements in patient outcomes. The company is headquartered in New York City and advances programs through regulatory engagement and commercialization efforts.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Axsome Therapeutics.
Axsome Therapeutics, Inc. (AXSM): A Bull Case Theory
2 weeks ago